BRENTUXIMAB VEDOTIN
Clinical trials for BRENTUXIMAB VEDOTIN explained in plain language.
Never miss a new study
Get alerted when new BRENTUXIMAB VEDOTIN trials appear
Sign up with your email to follow new studies for BRENTUXIMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare skin lymphoma: drug after transplant may stop cancer return
Disease control Not yet recruitingThis study tests whether giving brentuximab vedotin after a stem cell transplant can prevent early relapse in people with advanced cutaneous T-cell lymphoma (CTCL). About 84 adults aged 18-70 with CD30-positive mycosis fungoides who have had at least one prior treatment and are i…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for rare lymphoma: drug combo targets tough-to-treat cancer
Disease control Not yet recruitingThis study tests whether adding brentuximab vedotin to standard chemotherapy (R-CHP) works better for people newly diagnosed with a rare, aggressive lymphoma linked to the Epstein-Barr virus. About 25 adults will receive the combination and be followed for 2 years to see if the c…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 18, 2026 12:06 UTC